BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23566361)

  • 1. Oncological outcomes in patients with stage I testicular seminoma and nonseminoma: pathological risk factors for relapse and feasibility of surveillance after orchiectomy.
    Kobayashi K; Saito T; Kitamura Y; Nobushita T; Kawasaki T; Hara N; Takahashi K
    Diagn Pathol; 2013 Apr; 8():57. PubMed ID: 23566361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance.
    Kollmannsberger C; Tandstad T; Bedard PL; Cohn-Cedermark G; Chung PW; Jewett MA; Powles T; Warde PR; Daneshmand S; Protheroe A; Tyldesley S; Black PC; Chi K; So AI; Moore MJ; Nichols CR
    J Clin Oncol; 2015 Jan; 33(1):51-7. PubMed ID: 25135991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
    Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
    Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Observation versus adjuvant radiation or chemotherapy in the management of stage I seminoma: clinical outcomes and prognostic factors for relapse in a large US cohort.
    Soper MS; Hastings JR; Cosmatos HA; Slezak JM; Wang R; Lodin K
    Am J Clin Oncol; 2014 Aug; 37(4):356-9. PubMed ID: 23275274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.
    Ondrusova M; Ondrus D; Miskovska V; Kajo K; Szoldova K; Usakova V; Stastna V
    Int Urol Nephrol; 2015 Jul; 47(7):1143-7. PubMed ID: 25982582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort.
    Daugaard G; Gundgaard MG; Mortensen MS; Agerbæk M; Holm NV; Rørth M; von der Maase H; Christensen IJ; Lauritsen J
    J Clin Oncol; 2014 Dec; 32(34):3817-23. PubMed ID: 25267754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surveillance of stage I testicular seminoma: 20 years oncological results].
    Zores T; Mouracade P; Duclos B; Saussine C; Lang H; Jacqmin D
    Prog Urol; 2015 Apr; 25(5):282-7. PubMed ID: 25724863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of different post-orchiectomy management for stage I seminoma: Japanese multi-institutional study including 425 patients.
    Kamba T; Kamoto T; Okubo K; Teramukai S; Kakehi Y; Matsuda T; Ogawa O
    Int J Urol; 2010 Dec; 17(12):980-7. PubMed ID: 20955354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
    Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
    Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment burden in stage I seminoma: a comparison of surveillance and adjuvant radiation therapy.
    Leung E; Warde P; Jewett M; Panzarella T; O'Malley M; Sweet J; Moore M; Sturgeon J; Gospodarowicz M; Chung P
    BJU Int; 2013 Dec; 112(8):1088-95. PubMed ID: 23937685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage I testicular seminoma: results of adjuvant irradiation and surveillance.
    Warde P; Gospodarowicz MK; Panzarella T; Catton CN; Sturgeon JF; Moore M; Goodman P; Jewett MA
    J Clin Oncol; 1995 Sep; 13(9):2255-62. PubMed ID: 7666083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of clinical stage I testicular pure seminoma. Report on 42 patients and review of the literature.
    Porcaro AB; Antoniolli SZ; Schiavone D; Maffei N; Bassetto MA; Curti P
    Arch Ital Urol Androl; 2002 Jun; 74(2):77-80. PubMed ID: 12161941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for loss to follow-up during active surveillance of patients with Stage I seminoma.
    Endo T; Kawai K; Kamba T; Inai H; Uchida K; Miyazaki J; Kamoto T; Ogawa O; Nishiyama H
    Jpn J Clin Oncol; 2014 Apr; 44(4):355-9. PubMed ID: 24558127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome.
    Yoshida T; Kakimoto K; Takezawa K; Arai Y; Ono Y; Meguro N; Kinouchi T; Nishimura K; Usami M
    Int J Urol; 2009 Sep; 16(9):756-9. PubMed ID: 19659679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.
    Chau C; Cathomas R; Wheater M; Klingbiel D; Fehr M; Bennett J; Markham H; Lee C; Crabb SJ; Geldart T
    Ann Oncol; 2015 Sep; 26(9):1865-1870. PubMed ID: 26037797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance in stage I seminoma patients: a long-term assessment.
    Cummins S; Yau T; Huddart R; Dearnaley D; Horwich A
    Eur Urol; 2010 Apr; 57(4):673-8. PubMed ID: 19545941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in adjuvant therapy utilization in stage I seminoma: are they enough to prevent overtreatment?
    Kohut RM; Minnillo BJ; Kypriotakis G; Abouassaly R; Zhu H
    Urology; 2014 Dec; 84(6):1319-24. PubMed ID: 25432823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalizing, not patronizing: the case for patient autonomy by unbiased presentation of management options in stage I testicular cancer.
    Oldenburg J; Aparicio J; Beyer J; Cohn-Cedermark G; Cullen M; Gilligan T; De Giorgi U; De Santis M; de Wit R; Fosså SD; Germà-Lluch JR; Gillessen S; Haugnes HS; Honecker F; Horwich A; Lorch A; Ondruš D; Rosti G; Stephenson AJ; Tandstad T
    Ann Oncol; 2015 May; 26(5):833-838. PubMed ID: 25378299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of stage I testicular seminoma over a period of 49 years.
    Detti B; Scoccianti S; Villari D; Cipressi S; Sardaro A; Simontacchi G; Livi L; Gacci M; Cai T; Greto D; Desideri I; Biti G
    Onkologie; 2011; 34(10):510-4. PubMed ID: 21985849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An analysis of surveillance for stage I combined teratoma--seminoma of the testis.
    Thomas R; Dearnaley D; Nicholls J; Norman A; Sampson S; Horwich A
    Br J Cancer; 1996 Jul; 74(1):59-62. PubMed ID: 8679458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.